Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Turnstone announces Burgess’ move to executive chairman alongside pair of promotions; plus Fulgent, Centene FDS, Akouos and more

By Gunjan Ohri, Data Content Analyst
May 8, 2021 1:54 AM UTC

Turnstone Biologics Inc. President of R&D Mike Burgess will become executive chairman of R&D. The cancer immunotherapy company also promoted José Otero to CTO from SVP of technical operations and Saryah Azmat to CBO from SVP of business development and corporate strategy.

Genetic diagnostics company Fulgent Genetics Inc. (NASDAQ:FLGT) hired Lawrence Weiss as CMO. Weiss was CMO at NeoGenomics Inc. (NASDAQ:NEO). ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Akouos Inc.

Aspen Neuroscience Inc.

Centene Corp.

Cognito Therapeutics Inc.

Dermavant Sciences Ltd.

Expansion Therapeutics Inc.

Fsd Pharma Inc.